Prasinezumab, a groundbreaking drug targeting Parkinson's disease, shows promise in slowing motor deterioration, offering hope to millions grappling with the condition's challenges. Read this story
Prasinezumab, a groundbreaking drug targeting Parkinson's disease, shows promise in slowing motor deterioration, offering hope to millions grappling with the condition's challenges. Read this story
More from Tech Times | Parkinson's disease new drug shows promise slowing motor deterioration caused parkinsons disease Health